ClinicalTrials.gg
Not yet recruitingNCT07925164Updated Nov 9, 2026

Prevalence and Factors Associated With Depression Among Children and Adolescents With Type 1 Diabetes Mellituss

An observational study in Depression in Type 1 Diabetes Mellituss, sponsored by Asmaa Abdelnasser Madian. Not yet recruiting. Open to participants aged 7 Years to 16 Years. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Asmaa Abdelnasser Madian · Observational

Updated Nov 9, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
100
Ages
7 Years to 16 Years
Sex
All
01

Study summary

This is cross sectional study conducted at Sohag University Hospital to assess prevalence and factors associated with depression among children and adolescents with type 1 diabetes mellitus .The investigators will include the children and adolescents from 7 to 16 years who are diagnosed with type 1 diabetes mellitus

Read the detailed description

This is single-centre cross sectional study conducted and the paediatric endocrinology Department ,Sohag University Hospital ,Egypt study population.Childern and adolescents from 7 to 16 years diagnosed with type 1 diabetes mellitus to assess prevalence and factors associated with depression .Data collection :Demographic data,anthropometric data, clinical assessment,laboratory results ,depression assessment using the Children Depression Inventory (CDI) .Objectives:to assess the prevalence and factors associated with depression among childern and adolescents with type 1 diabetes mellitus .This study does not involve any experimental interventions .All investigators and management will be according to standard hospital protocols

02

Conditions studied

  • Depression in Type 1 Diabetes Mellituss
03

In context

Depression

8,577 studies on the registry are indexed under Depression; 1,720 are open to participants now.

This study's planned enrollment of 100 is below the median of 175 across 1,257 observational studies indexed under Depression.

Browse Depression studies →

Lead sponsor

This is the only study on the registry with Asmaa Abdelnasser Madian as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

paediatric patient from 7 to 16 years diagnosed with type 1 diabetes mellitus and have depression who are followed in Paediatric Endocrinology Department ,Sohag University Hospital .

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adolescents aged 7-16 years . Diagnosed with type 1 diabetes mellitus for at least 6 months . On insulin therapy . Able to understand and complete the questionnaires . Consent from parent/guardian and assent from the adolescent

Exclusion criteria

Exclusion Criteria:

  • Adolescents with type 2 diabetes or secondary diabetes

    • Severe cognitive impairment preventing questionnaire completion
    • Acute illness at time of assessment
    • Diagnosed psychiatric disorders prior to T1DM diagnosis.
    • Refusal to participate
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Children from 7 to 16 years diagnosed depression with type 1 diabetes mellitus

    Children and adolescents from 7 to 16 years diagnosed with type 1 diabetes mellitus have depression who are followed at Sohag University Hospital

    Other: Observation follow-up

Interventions

  • OtherObservation follow-up

    No experimental intervention .Data will be collected from routine clinical care,medical records ,and follow up visits according to standard hospital protocols

06

What researchers measure

Primary outcomes

  1. Depression in type 1 diabetes mellitus

    Prevalence and factors associated with depression among children and adolescents with type 1 diabetes mellitus at Sohag University Hospital

    Time frame: 6 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared due to patient privacy and data protection policies at Sohag University Hospital

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for Jan 2027, 2 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 29, 2026
First posted
Nov 9, 2026
StartEst.
Nov 2026
Primary completionEst.
Jan 2027
CompletionEst.
Feb 2027
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07925164
Lead sponsor
Asmaa Abdelnasser Madian
Responsible party
Asmaa Abdelnasser Madian (paediatric resident, Sohag University) — Sponsor-investigator
First posted
Nov 9, 2026
Start date
Nov 2026 (estimated)
Primary completion
Jan 2027 (estimated)
Completion
Feb 2027 (estimated)
Last update
Nov 9, 2026

Study contacts

Asmaa Abdelnaser Madian, Resident doctor
Contact
asmaa.abdelnaser@med.sohag.edu.eg
01090850159
Asmaa Abdelnaser Madian, Resident doctor
principal investigator · Sohag University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion